FDA Clears First Generic of Isoproterenol (Isuprel)

Nexus Pharmaceuticals’ version of the cardiac injection drug isoproterenol hydrochloride received expedited FDA review as a potential first generic.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply